Developing Global Research Capacity

Aeras fosters knowledge sharing and research capacity strengthening in multiple countries with a high TB burden. The value of collaborating with Aeras goes beyond the immediate benefits of successful TB vaccine research.

Aeras has helped establish and support clinical research capacity throughout Africa, including trial sites in South Africa, Tanzania, and Zambia. Collateral benefits to clinical trial sites include equipment and facilities, skills development, high-quality jobs for local researchers, healthcare workers and other staff, and generally a higher standard of healthcare for trial participants.

Aeras recently worked with the AIDS Vaccine Advocacy Coalition, clinical trial site staff, community advisory boards, TB Alliance and Treatment Action Group to draft Good Participatory Practice Guidelines for TB vaccine clinical trials – a set of guidelines (or standards) that any research team can apply to meaningfully involve key stakeholders in different aspects of the research, before, after, and in between trials.